Location History:
- Herts, GB (2001)
- Letchworth, GB (2001 - 2003)
- Cambridge, GB (2003 - 2017)
Company Filing History:
Years Active: 2001-2017
Title: The Innovative Contributions of David Loakes
Introduction
David Loakes is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of peptide technology, holding a total of 12 patents. His work focuses on developing innovative methods for creating multispecific peptides and modifying peptide ligands.
Latest Patents
One of his latest patents is related to multispecific peptides. This invention outlines a method for providing a multispecific peptide ligand that comprises a polypeptide covalently linked to a molecular scaffold at three or more amino acid residues. This peptide is capable of binding to two or more separate targets. The method includes several steps, such as providing a repertoire of polypeptides with reactive groups and joining loops from different polypeptides to form a composite structure.
Another notable patent involves structured peptide processing. This invention describes a method for modifying peptide ligands that are covalently linked to a molecular scaffold at two or more amino acid residues. The process includes exposing the peptide ligands to proteases and sorting them based on the extent of proteolytic cleavage.
Career Highlights
David Loakes has worked with several notable companies in the biotechnology sector. He has been associated with Bicycle Therapeutics Limited and Amersham Pharmacia Biotech UK Limited. His experience in these organizations has contributed to his expertise in peptide technology and innovation.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including Daniel M Brown and Alan L Hamilton. These partnerships have likely enhanced his research and development efforts in the field.
Conclusion
David Loakes is a distinguished inventor whose work in peptide technology has led to significant advancements in the field. His innovative patents and collaborations reflect his commitment to pushing the boundaries of scientific research.